Study of the Safety, Tolerability, and Pharmacokinetics of REGN6490 in Healthy Japanese Adult Volunteers

NCT04616105 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

19

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Healthy Volunteer

Interventions

DRUG: REGN6490
DRUG: Placebo

Sponsor

Regeneron Pharmaceuticals